Human trials:
In order to address the high patient withdrawal rates and speed up the trial recruitment, PharmAust and CMAX have approached Consultant Medical Oncologists in NALHN (Northern Adelaide Local Health Network) and SALHN (Southern Adelaide Local Health Network) for participation in the trial. The company will report on agreements with further centres to participate in the trial soon.
AND
no adverse side effects in the patient who completed the 28 day stint.
Ann: Shareholder Update - Human & Canine Trials, page-2
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $86.77M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.8¢ | 19.5¢ | $67.86K | 346.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 360690 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 792103 | 8 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |